Zinc Ion

Zinc Ion

SCHEMBL2583379

O=C([O-])CCCCCNC(=O)CCCCC(S)CCS.O=C([O-])CCCCCNC(=O)CCCCC(S)CCS.[NaH].[Zn+2]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 11/20 0.40
HDAC4 P56524 11/20 0.40
HDAC1 Q13547 11/20 0.40
HDAC7 Q8WUI4 11/20 0.40
HDAC2 Q92769 11/20 0.40
HDAC10 Q969S8 11/20 0.40
HDAC11 Q96DB2 11/20 0.40
HDAC8 Q9BY41 11/20 0.40
HDAC6 Q9UBN7 11/20 0.40
HDAC9 Q9UKV0 11/20 0.40
HDAC5 Q9UQL6 11/20 0.40
DNM1 Q05193 2/20 0.36
CASP2 P42575 1/20 0.35
FAAH O00519 1/20 0.35
EPHX2 P34913 3/20 0.33
NAAA Q02083 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL3337707 0.99 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL3276632 0.96 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
Zinc Ion SCHEMBL2580314 0.96 HDAC3 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
Zinc Ion SCHEMBL3337795 0.94 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL3276879 0.92 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
Zinc Ion SCHEMBL2581231 0.92 HDAC3 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL3276636 0.86 EPHX2 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
Dihydrolipoic Acid SCHEMBL4761909 0.85 NFKB1 (0.38)
Zinc Ion SCHEMBL2575366 0.84 PTPN1 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2581324 0.84 EPHX2 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048911-B2 Melanin eliminator preparation OGA Research, Inc. (JP) 2011-11-01 US disclosed
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION OGA RESEARCH, INC (JP) 2009-04-09 US disclosed
US-20060122100-A1 Melanin extinguisher OGA RESEARCH, INCORPORATED (JP) 2006-06-08 US disclosed
EP-1547590-A1 MELANIN EXTINGUISHER Oga Research, Incorporated (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122100-A1 Melanin extinguisher TYR, MC1R, MITF HDAC3 2885/4885HDAC4 3186/4885HDAC1 1609/4885
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION TYR, MC1R, MCHR1 HDAC3 3339/4885HDAC4 3112/4885HDAC1 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.